Diagnosis and treatment of pancreatic acinar cell carcinoma

doi:10.3877/cma.j.issn.2095-3232.2024.04.008

Abstract

Abstract:

Pancreatic acinar cell carcinoma (PACC) is a malignant epithelial tumor arising from pancreatic epithelium, which is rare in clinical practice due to low incidence, and it has no specific clinical manifestations. Previous studies have reported that PACC accounts for merely 1%-2% of exocrine pancreatic tumors and 0.44% of pancreatic malignant tumors. This disease is challenging to diagnose, has low resection rates, and easily metastasizes. However, the prognosis is better than that of pancreatic ductal adenocarcinoma. Understanding and mastering clinical diagnosis and treatment of PACC can improve diagnostic rate and clinical prognosis.

Key words: Pancreatic acinar cell carcinoma, Pancreatic exocrine tumor, Surgical treatment, Comprehensive treatment

Shuai Wu, Jiaoxing Wu, Fangzhou Wang, Peize Yang, Shunbin Dong, Zheng Wang, Zheng Wu. Diagnosis and treatment of pancreatic acinar cell carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(04): 487-491.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2024.04.008

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2024/V13/I04/487

Figures/Tables 3

References 21

[1]	Paseiro-Crespo G, García-Nebreda M, Roldán Cortés D, et al. Primary pure pancreatic-type acinar cell carcinoma of the stomach: a rare entity with a difficult diagnosis and review of the literature[J]. Int J Surg Pathol, 2022, 30(5):528-538.
[2]	Kim KM, Kim CY, Hong SM, et al. A primary pure pancreatic-type acinar cell carcinoma of the stomach: a case report[J]. Diagn Pathol, 2017, 12(1):10.
[3]	Petrova E, Wellner J, Nording AK, et al. Survival outcome and prognostic factors for pancreatic acinar cell carcinoma: retrospective analysis from the German cancer registry group[J]. Cancers, 2021, 13(23):6121.
[4]	Chaudhary P. Acinar cell carcinoma of the pancreas: a literature review and update[J]. Indian J Surg, 2015, 77(3):226-231.
[5]	Ciardiello D, Urbano F, Zamboni G, et al. Left abdominal mass with carcinosis: unusual presentation of pancreatic acinar cell carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2023, 22(4):412-414.
[6]	Al-Hader A, Al-Rohil RN, Han H, et al. Pancreatic acinar cell carcinoma: a review on molecular profiling of patient tumors[J]. World J Gastroenterol, 2017, 23(45):7945-7951.
[7]	Singh S, Gorouhi F, Konia T, et al. Pancreatic acinar cell carcinoma-induced panniculitis[J]. JAAD Case Rep, 2018, 4(7):719-721.
[8]	la Rosa S, Adsay V, Albarello L, et al. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers[J]. Am J Surg Pathol, 2012, 36(12):1782-1795.
[9]	Chen H, Xu Z, Shen Z, et al. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma[J]. Eur J Surg Oncol, 2022, 48(5):1062-1067.
[10]	Baek KA, Kim SS, Lee HN. Typical CT and MRI features of pancreatic acinar cell carcinoma: main teaching point: typical imaging features of pancreatic acinar cell carcinoma are relatively large, with a well-defined margin, exophytic growth, and heterogeneous enhancement[J]. J Belg Soc Radiol, 2019, 103(1):43.
[11]	Luo Y, Hu G, Ma Y, et al. Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: two case reports and literature review[J]. Medicine, 2017, 96(38):e7904.
[12]	Busch E, Werft W, Bougatf N, et al. Metastatic acinar cell carcinoma of the pancreas: a retrospective cohort study on systemic chemotherapy and review of the literature[J]. Pancreas, 2021, 50(3):300-305.
[13]	Uemura S, Maeda H, Tanioka N, et al. Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: a case report[J]. Cancer Rep, 2022, 5(9):e1648.
[14]	Sridharan V, Mino-Kenudson M, Cleary JM, et al. Pancreatic acinar cell carcinoma: a multi-center series on clinical characteristics and treatment outcomes[J]. Pancreatology, 2021: S1424-S3903(21)00162-9.
[15]	Xu JY, Guan WL, Lu SX, et al. Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature[J]. Clin Med Insights Oncol, 2022, 16: 11795549221090186.
[16]	Dreikhausen L, Schulte N, Belle S, et al. Pancreatic acinar cell carcinoma with germline BRCA2 mutation and severe pancreatic panniculitis: a case report[J]. Visc Med, 2021, 37(5):447-450.
[17]	Kryklyva V, Haj Mohammad N, Morsink FHM, et al. Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review[J]. Cancer Biol Ther, 2019, 20(7):949-955.
[18]	Gupta M, Sherrow C, Krone ME, et al. Targeting the NTRK fusion gene in pancreatic acinar cell carcinoma: a case report and review of the literature[J]. J Natl Compr Canc Netw, 2021, 19(1):10-15.
[19]	Wisnoski NC, Townsend CM Jr, Nealon WH, et al. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma[J]. Surgery, 2008, 144(2):141-148.
[20]	Nie D, Shi B, Zhang T, et al. The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: a population-based study[J]. PLoS One, 2020, 15(12):e0243164.
[21]	Schmidt CM, Matos JM, Bentrem DJ, et al. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma[J]. J Gastrointest Surg, 2008, 12(12):2078-2086.

分类	要点
临床表现	非特异性症状：体重减轻、恶心呕吐、黑便、乏力等
	高脂肪酶血症（10%～15%患者）：皮下脂肪坏死多发性结节灶^[7]，骨脂肪坏死导致松质骨硬化性病变引起的多关节痛
实验室检查	血清脂肪酶升高
	肿瘤标志物升高无一致性，部分患者AFP升高
影像学表现	外生性、圆形或椭圆形、边缘清楚、低血管性肿块，早期病灶多为实性，而晚期病灶可出现坏死表现为囊实性改变。增强CT表现为局限和均匀性强化，但强化程度低于周围胰腺
组织病理学	有不同程度的腺泡分化，但细胞排列缺乏整齐和致密性，细胞具有基向核、单个突出的核仁和嗜酸性颗粒状细胞质
	PAS染色和丁酸酯酶染色阳性，抗胰蛋白酶、凝乳蛋白酶、脂肪酶和淀粉酶阳性
	通常腺瘤性大肠息肉病（APC）基因突变和β-catenin通路异常

分类	要点
临床表现	非特异性症状：体重减轻、恶心呕吐、黑便、乏力等
	高脂肪酶血症（10%～15%患者）：皮下脂肪坏死多发性结节灶^[7]，骨脂肪坏死导致松质骨硬化性病变引起的多关节痛
实验室检查	血清脂肪酶升高
	肿瘤标志物升高无一致性，部分患者AFP升高
影像学表现	外生性、圆形或椭圆形、边缘清楚、低血管性肿块，早期病灶多为实性，而晚期病灶可出现坏死表现为囊实性改变。增强CT表现为局限和均匀性强化，但强化程度低于周围胰腺
组织病理学	有不同程度的腺泡分化，但细胞排列缺乏整齐和致密性，细胞具有基向核、单个突出的核仁和嗜酸性颗粒状细胞质
	PAS染色和丁酸酯酶染色阳性，抗胰蛋白酶、凝乳蛋白酶、脂肪酶和淀粉酶阳性
	通常腺瘤性大肠息肉病（APC）基因突变和β-catenin通路异常

Please choose a citation manager

Content to export